Pacific Biosciences of California, Inc. (PACB)
PacBio's (PACB) Revio System to Boost Novogene's German Lab
PacBio (PACB) announces that Novogene is set to use PACB's Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany.
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
PacBio (PACB) and Form Bio to Boost AAV Industry Development
PacBio (PACB) and Form Bio collaborate to form an expert AAV Working Group to introduce essential tools for AAV development and research professionals.
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.37, indicating a +0.74% shift from the previous trading day.
Reasons to Retain PacBio (PACB) Stock in Your Portfolio
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Pacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Pacific Biosciences (PACB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
